BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

582 related articles for article (PubMed ID: 31367156)

  • 1. Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice.
    Quach DT; Hiyama T; Gotoda T
    World J Gastroenterol; 2019 Jul; 25(27):3546-3562. PubMed ID: 31367156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication may influence timing of endoscopic surveillance for gastric cancer in patients with gastric precancerous lesions: A retrospective study.
    Dore MP; Cipolli A; Ruggiu MW; Manca A; Bassotti G; Pes GM
    Medicine (Baltimore); 2018 Jan; 97(4):e9734. PubMed ID: 29369216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biopsy strategies for endoscopic screening of pre-malignant gastric lesions.
    Zhang M; Liu S; Hu Y; Bao HB; Meng LN; Wang XT; Xu Y; Zhao J; Lu B
    Sci Rep; 2019 Oct; 9(1):14909. PubMed ID: 31624309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy.
    Huang RJ; Ende AR; Singla A; Higa JT; Choi AY; Lee AB; Whang SG; Gravelle K; D'Andrea S; Bang SJ; Schmidt RA; Yeh MM; Hwang JH
    Gastrointest Endosc; 2020 Jan; 91(1):70-77.e1. PubMed ID: 31425693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surveillance of patients with gastric precancerous conditions.
    Lage J; Uedo N; Dinis-Ribeiro M; Yao K
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):913-922. PubMed ID: 27938786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for and surveillance of gastric cancer.
    Compare D; Rocco A; Nardone G
    World J Gastroenterol; 2014 Oct; 20(38):13681-91. PubMed ID: 25320506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma.
    Banks M; Graham D; Jansen M; Gotoda T; Coda S; di Pietro M; Uedo N; Bhandari P; Pritchard DM; Kuipers EJ; Rodriguez-Justo M; Novelli MR; Ragunath K; Shepherd N; Dinis-Ribeiro M
    Gut; 2019 Sep; 68(9):1545-1575. PubMed ID: 31278206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Controlling Gastric Cancer in a World of Heterogeneous Risk.
    Huang RJ; Laszkowska M; In H; Hwang JH; Epplein M
    Gastroenterology; 2023 Apr; 164(5):736-751. PubMed ID: 36706842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Precancerous gastric conditions in high Helicobacter pylori prevalence areas: comparison between Eastern European (Lithuanian, Latvian) and Asian (Taiwanese) patients.
    Jonaitis L; Ivanauskas A; Janciauskas D; Funka K; Sudraba A; Tolmanis I; Krams A; Stirna D; Vanags A; Kupcinskas L; Leja M; Lin JT
    Medicina (Kaunas); 2007; 43(8):623-9. PubMed ID: 17895638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Follow-up of Gastric Precancerous Lesions in a Low GC Incidence Area.
    Chapelle N; Péron M; Quénéhervé L; Bourget A; Leroy M; Touchefeu Y; Cauchin E; Coron E; Mosnier JF; Matysiak-Budnik T
    Clin Transl Gastroenterol; 2020 Dec; 11(12):e00237. PubMed ID: 33512802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of gastric cancer: who, when, and how.
    Lin JT
    Clin Gastroenterol Hepatol; 2014 Jan; 12(1):135-8. PubMed ID: 24107396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
    Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
    Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019.
    Pimentel-Nunes P; Libânio D; Marcos-Pinto R; Areia M; Leja M; Esposito G; Garrido M; Kikuste I; Megraud F; Matysiak-Budnik T; Annibale B; Dumonceau JM; Barros R; Fléjou JF; Carneiro F; van Hooft JE; Kuipers EJ; Dinis-Ribeiro M
    Endoscopy; 2019 Apr; 51(4):365-388. PubMed ID: 30841008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands.
    de Vries AC; van Grieken NC; Looman CW; Casparie MK; de Vries E; Meijer GA; Kuipers EJ
    Gastroenterology; 2008 Apr; 134(4):945-52. PubMed ID: 18395075
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastric atrophy, metaplasia, and dysplasia: a clinical perspective.
    Kapadia CR
    J Clin Gastroenterol; 2003; 36(5 Suppl):S29-36; discussion S61-2. PubMed ID: 12702963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OLGA Gastritis Staging for the Prediction of Gastric Cancer Risk: A Long-term Follow-up Study of 7436 Patients.
    Rugge M; Genta RM; Fassan M; Valentini E; Coati I; Guzzinati S; Savarino E; Zorzi M; Farinati F; Malfertheiner P
    Am J Gastroenterol; 2018 Nov; 113(11):1621-1628. PubMed ID: 30333540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility and cost-effectiveness of using magnification chromoendoscopy and pepsinogen serum levels for the follow-up of patients with atrophic chronic gastritis and intestinal metaplasia.
    Dinis-Ribeiro M; da Costa-Pereira A; Lopes C; Moreira-Dias L
    J Gastroenterol Hepatol; 2007 Oct; 22(10):1594-604. PubMed ID: 17845687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prevalence of Helicobacter pylori infection and gastric cancer precursor lesions in patients with dyspepsia].
    Muller LB; Fagundes RB; Moraes CC; Rampazzo A
    Arq Gastroenterol; 2007; 44(2):93-8. PubMed ID: 17962851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer screening in low incidence populations: Position statement of AEG, SEED and SEAP.
    Cubiella J; Pérez Aisa Á; Cuatrecasas M; Díez Redondo P; Fernández Esparrach G; Marín-Gabriel JC; Moreira L; Núñez H; Pardo López ML; Rodríguez de Santiago E; Rosón P; Sanz Anquela JM; Calvet X;
    Gastroenterol Hepatol; 2021 Jan; 44(1):67-86. PubMed ID: 33252332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.